← All trials
NCT01496339
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Dec 1, 2013
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- S-Evans Biosciences Co.,Ltd.Lead sponsor
- S-Evans Biosciences Co.,Ltd.Overall official - principal investigator
- Zhejiang UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.